Vantobra inhaled tobramycin regulatory update

EMA's CHMP said it received an MAA from Pari for Vantobra inhaled tobramycin to treat Pseudomonas aeruginosa lung infection in patients with cystic fibrosis (CF). The aerosolized formation of tobramyc...